Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IGM Biosciences, Inc. - Common Stock (NQ: IGMS )

1.430 +0.060 (+4.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGM Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
IGM Biosciences Announces Third Quarter 2023 Financial Results
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at Two Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
From IGM Biosciences, Inc.
Via GlobeNewswire
Analyst Ratings for IGM Biosciences
Via Benzinga
The Latest Analyst Ratings for IGM Biosciences
Via Benzinga
The Latest Analyst Ratings for IGM Biosciences
Via Benzinga
Analyst Expectations for IGM Biosciences's Future
Via Benzinga
Recap: IGM Biosciences Q1 Earnings
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2... 
Via Benzinga
IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Second Quarter 2023 Financial Results
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From IGM Biosciences, Inc.
Via GlobeNewswire
Tech-Heavy Nasdaq Firmly Higher Midday
Stocks are attempting a rebound this afternoon, following their third-straight day of losses. 
Via Talk Markets
Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Why IGM Biosciences (IGMS) Stock Is Trading Higher
IGM Biosciences Inc (NASDAQ: IGMS) shares are trading higher by 11.69% to $9.89 Thursday morning after the company priced upsized public offering and concurrent private placement at $8.00 per share. 
Via Benzinga
US Stocks Lower Following Initial Jobless Claims Report
U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell... 
Via Benzinga
IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Announces Proposed Public Offering and Concurrent Private Placement
From IGM Biosciences, Inc.
Via GlobeNewswire
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
Via Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the Jefferies Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
Imvotamab, a CD20 x CD3 bispecific monoclonal antibody, offers potential for deeper B cell depletion than currently approved therapies 
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
IGM Biosciences to Present at Two Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023
Presentations highlight data from across all oncology pipeline programs 
From IGM Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.